David Connelly PhD

Dr David Connelly has over 25 years’ experience in the pharmaceutical and CRO industry in areas including clinical trial design, operations, monitoring, biostatistics and data management. He also has extensive experience of working with top pharmaceutical company executives in process re-engineering, performance and change management, design and deployment of new technology.

As principal founder and CEO of Cmed (in early 2000), David has led the growth and development of Cmed into a leading, multinational full service CRO which has particular strengths in oncology, rare diseases and the development and deployment of advanced data capture and management technology. David has a PhD in Pharmacology and has lived and worked in the UK, Switzerland and the US.